F.D.A. Staff Raises Concerns About Arthritis Drug
Tuesday, May 8, 2012 - 01:20
in Health & Medicine
As an advisory panel prepared to consider whether to recommend federal approval of Pfizer’s rheumatoid arthritis pill, F.D.A. documents raise safety questions.
Read the whole article on NY Times Health
More from NY Times Health
Related
- Wide variability in rheumatoid arthritis drug suggests alternative dosing should be consideredTue, 4 Nov 2008, 13:35:52 EST
- Rheumatoid arthritis breakthroughTue, 11 Nov 2008, 20:22:03 EST
- Novel drugs selectively target pathway important in rheumatoid arthritisTue, 13 Jan 2009, 16:57:27 EST
- New biologic drug is effective against rheumatoid arthritisTue, 6 Oct 2009, 19:52:33 EDT
- Rheumatoid arthritis: Worse in women?Tue, 13 Jan 2009, 19:36:18 EST